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Letter to the Editor 
Clinical Microbiology
First Case of Trueperella bernardiae Bacteremia in an 
Immunocompromised Patient in Korea
Juhye Roh , M.D., Myungsook Kim , M.T., Ph.D., Dokyun Kim , M.D., Ph.D., Dongeun Yong , M.D., Ph.D.,  
and Kyungwon Lee , M.D., Ph.D.
Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea 
Dear Editor,
Trueperella spp. are facultative anaerobic gram-positive bacilli 
usually found in the mammalian genital tract [1]. Of the five 
Trueperella spp., T. bernardiae and T. pyogenes have been iso-
lated in human clinical specimens [2, 3]. T. bernardiae has 
been reported as an opportunistic pathogen in chronic osteitis, 
prosthetic joint infection, and brain abscess cases [4-6]. How-
ever, bloodstream infections caused by T. bernardiae have been 
reported in only a few cases, mostly in immunocompromised 
patients [7, 8]. We report the first case of T. bernardiae bactere-
mia in Korea. The Institutional Review Board for Human Re-
search, Yonsei University, Severance Hospital, Seoul, Korea, ap-
proved this study (approval number: 4-2019-0343) and waived 
the need for informed consent.
An 83-year old woman with a history of diabetes mellitus, cere-
brovascular disease, and paroxysmal atrial fibrillation was trans-
ferred to the emergency room at Severance Hospital from a ge-
riatric hospital because of uncontrolled fever and hypotension in 
August 2016. Three days prior to admission, she had been treated 
with fluoroquinolone (200 mg, twice a day) in the geriatric hos-
pital because of a Klebsiella pneumoniae urinary tract infection. 
In the emergency room, her mean blood pressure was 42 mmHg, 
heart rate was 58 beats/minutes, and body temperature was 35.8°C. 
Laboratory tests showed a blood leukocyte count of 14.73×109/L, 
neutrophil count of 13.04×109/L (88.5% of total leukocyte count), 
C-reactive protein (CRP) level of 1,668.57 nmol/L, and procalci-
tonin level of 3.91 µg/L. As K. pneumoniae septic shock was 
suspected, empirical antimicrobial treatment with meropenem 
was initiated. Ten milliliter of blood were collected in three sets 
of culture vials, including BacT/Alert FA Plus (bioMérieux, 
Marcy-l’Étoile, France) and BacT/Alert FN Plus (bioMérieux), 
which were incubated in a BacT/ALERT 3D automated blood 
culture system (bioMérieux) immediately. After four-day incuba-
tion, positive signals for bacterial growth were identified in two 
FA and two FN culture vials. Gram-positive cocci and gram-pos-
itive bacilli were observed on the smear preparation from the 
positive-signal culture vials. Following subculturing on blood 
agar, white, medium-sized colonies and grayish, pinpoint colo-
nies were observed. The bacterial species were identified as S. 
aureus (identification log score: 2.163) and T. bernardiae (iden-
tification log score: 1.981), respectively, using a Bruker Biotyper 
matrix-assisted laser desorption ionization–time of flight mass 
spectrometry (MALDI-TOF MS) system (Bruker Daltonics, Bre-
men, Germany). Because of the low identification log score (un-
der 2.0) for the latter isolate, indicating correct identification at 
the genus level, the 1,366 bp 16S rRNA gene was sequenced 
by Sanger sequencing and compared with the ezBiocloud data-
base (https://www.ezbiocloud.net/identify). This showed 99.85% 
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identity with GenBank sequence X79224 (T. bernardiae). Anti-
microbial susceptibility was determined via gradient diffusion 
using an ETEST strip (bioMérieux) on Mueller-Hinton agar (Difco 
Laboratories, Detroit, MI, USA), according to the CLSI guidelines 
[9]. The isolate was resistant to penicillin G (minimum inhibitory 
concentration [MIC], 4 µg/mL) and erythromycin (MIC, 3 µg/mL) 
and was susceptible to gentamicin (MIC, 0.023 µg/mL) and van-
comycin (MIC, 0.38 µg/mL). 
A follow-up blood culture on the third day of hospitalization 
showed continual growth of both S. aureus and T. bernardiae; 
thus, antimicrobial treatment with teicoplanin (400 mg, once a 
day) was initiated. After 11 days of teicoplanin treatment, the 
patient’s mean blood pressure was 93 mmHg, her fever sub-
sided, and CRP level decreased to 69.52 nmol/L. The follow-up 
blood culture was also negative for bacterial growth. Following 
conservative management, the patient was discharged 47 days 
post-admission. 
As the number of immunocompromised patients has increased 
rapidly over the past decades, microorganisms previously con-
sidered to be commensal are now regarded as significant patho-
gens [10]. Coryneform gram-positive bacilli are common flora of 
the skin and have been considered contaminants when recov-
ered from blood cultures [8]. However, in our case, T. bernar-
diae isolates were identified from multiple sets of blood culture 
vials and two consecutive blood cultures on separate days. In 
addition, clinical improvement and bacterial elimination were 
observed following appropriate antimicrobial treatment. There-
fore, we conclude that in our case, T. bernardiae constitutes a 
clinically significant pathogen rather than an incidental contami-
nant. 
Whether the interaction between T. bernardiae and other bac-
teria is synergistic or competitive is not clear. Polymicrobial in-
fection of T. bernardiae with other bacteria has been previously 
reported (Table 1). Bemer, et al. [4] reported a case of an im-
munocompromised patient with chronic osteitis caused by poly-
microbial infection, and Clarke, et al. [10] reported a case of nec-
rotizing fasciitis caused by Morganella morganii and T. bernar-
diae co-infection. Because of the slow growing nature of T. ber-
nardiae, other co-infecting bacteria could hinder accurate diag-
nosis of T. bernardiae infection. In addition, adequate antimicro-
bial treatment effective against T. bernardiae infection should be 
considered for immunocompromised patients, although this 
bacterium is considered to be less virulent than others. In this 
case, the anti-staphylococcal agents effectively treated the T. 
Table 1. Previous reports of polymicrobial infection of Trueperella bernardiae with other bacteria
Patient characteristics Bemer, et al. [4] Clarke, et al. [10] This case
Age (yr) 63 62 83
Sex Male Female Female
Past medical history Tuberculous arthritis of knee Diabetes mellitus, Hypertension
Chronic obstructive pulmonary disease
Diabetes mellitus
Cerebrovascular disease
Paroxysmal atrial fibrillation
Present morbidity Bacterial osteitis Abdominal wall abscess with cellulitis Bacteremia
Polymicrobial infection Staphylococcus aureus Morganella morganii Staphylococcus aureus
Specimen Synovial fluid Deep wound abscess Blood
Antimicrobial susceptibility
   Method Disk diffusion Etest Etest
   Penicillin S S R
   Clindamycin S S NT
   Gentamicin S NT S
   Erythromycin S S R
   Vancomycin S S S
   Trimethoprim-sulfamethoxazole S S NT
Antimicrobial treatment* Clindamycin, fusidic acid Piperacillin-tazobactam, vancomycin Teicoplanin
Prognosis Recovered Recovered Recovered
*Appropriate antimicrobials effective against T. bernardiae infection are indicated in bold.
Abbreviations: NT, not tested; R, resistant; S, susceptible.
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bernardiae infection. 
In conclusion, we report a case of T. bernardiae bacteremia 
confirmed by MALDI-TOF MS and 16S rRNA sequencing. This 
case increases our understanding on T. bernardiae and its patho-
genicity in immunocompromised patients.
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